News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Florez Lab: Meet the Co-Chairs of the Precision Medicine Symposium
Florez Lab/X
Oct 18, 2024, 18:40

Florez Lab: Meet the Co-Chairs of the Precision Medicine Symposium

Florez Lab shared a post on X:

“Meet the Co-Chairs of the Precision Medicine Symposium: Narjust Florez, Thoracic Oncologist at Dana-Farber Cancer Institute & Harvard Medical School faculty and our lab head is one of the co-chairs.

Joining her are experts Dr. Andre H. Goy & Dr. Monique Hartley-Brown.”

More posts featuring Florez Lab.

Andre H. Goy cancer Education event Florez Lab healthcare Medical Research Monique Hartley-Brown Narjust Florez OncoDaily Oncology Precision Medicine Symposium
Special Coverage
Science
Dec 21, 2024, 09:06
Toni Choueiri: The Final Analysis of the JAVELIN Renal 101 trial
Blog
Dec 21, 2024, 09:00
Miriam Mutebi: Does Nipple and Areola Size Matter?
Science
Dec 21, 2024, 08:51
Wafik S. El-Deiry: Our recent review on Targeting the SMURF2-HIF1α axis
Science
Dec 21, 2024, 08:48
Oncology Brothers: Another ALK inhibitor gets FDA approval
Science
Dec 21, 2024, 08:42
Eric K. Singhi: Decoding clinical trial jargon
Science
Dec 21, 2024, 08:37
Gustavo Viani: The Role of Radiotherapy on the management of HCC
Science
Dec 21, 2024, 08:29
Bishal Gyawali: The case of cancer drug Xtandi
Blog
Dec 21, 2024, 08:18
Sami (Papacek) Mansfield: Why is muscle health so important among cancer survivers?
Career
Dec 21, 2024, 08:12
Rishabh Singh: Honored to receive the Mary Draeger Schultz Scholarship 2024
Science
Dec 21, 2024, 07:56
Predictors of Discharge With Supplemental Oxygen After Lobectomy for Lung Cancer
Career
Dec 21, 2024, 07:45
OncoInfluencers to Follow on Social Media: Dr. Liang Cheng
Insight
Dec 21, 2024, 07:31
Update on U.S. regulatory review of subcutaneous amivantamab for EGFR + lung cancer